Posted: 1 September 2022
Event: 20 – 21 October 2022
CCRM Australia and Convergence Science Network are hosting the Business of Regenerative Medicine Asia Pacific Symposium from 20th-21st October 2022 in Melbourne, Australia. The two-day program will be hosted at Bio21 Institute of Molecular Science and Biotechnology, Parkville, VIC 3052.
Modelled on the successful Business of Regenerative Medicine Meetings held in North America, our symposium will unite the field’s leading organizations, industry players, business talent and investigative minds to share their considerable knowledge and “in the trenches” experience. This comprehensive and informative program will include presentations, panel discussions, case study analyses, networking and more.
The program themes include: a snapshot of the global regenerative medicine industry, commercialisation, investment, regulatory and clinical trials, and operations.
We will welcome up to 100 delegates from Asia Pacific and globally including biotechnology executives, investors and analysts, technology transfer personnel, junior and senior bio-entrepreneurial scientists, managers in the for-profit, not-for-profit and Government sector.
Day 1 – 20 October
Session 1 – Snapshot of the global regenerative medicine industry
Session 2 – Commercialisation
Session 3 – Investment
Day 2 – 21 October
Session 4 – Platinum sponsor session
Session 5 – Regulatory
Session 6 – Operations
Early bird opens: 1 July – 16 September
Regular Registration opens: 17 September